Trial · NCT02900729
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in average 24-hour systolic blood pressure by ambulatory blood pressure monitoring from baseline | 3 months post-randomization | |
| Secondary | Incidence of achieving target blood pressure | 6 months post-randomization | Target blood pressure is defined as daytime ambulatory blood pressure \<135/85mmHg, nighttime ambulatory blood pressure \<120/70mmHg or average 24-hour ambulatory blood pressure \<130/80mmHg, respectively |
| Secondary | Change in daytime and nighttime ambulatory systolic blood pressure from baseline | 3 months post-randomization | |
| Secondary | Change in 24 hour average, daytime and nighttime ambulatory diastolic blood pressure from baseline | 3 months post-randomization | |
| Secondary | Change in serum creatinine from baseline | 6 months post-randomization | |
| Secondary | Incidence of adverse event | Through study completion, up to 6 months | |
| Other | Change in 24 hour average, daytime and nighttime ambulatory systolic/diastolic blood pressure from baseline | 6 months post-randomization | |
| Other | Change in office systolic/diastolic blood pressure from baseline | 6 months post-randomization | |
| Other | Change in patient-recorded home systolic/diastolic blood pressure from baseline | 6 months post-randomization | |
| Other | Incidences of achieving reductions of ≥ 5 mmHg, ≥ 10 mmHg, ≥15 mmHg, and ≥ 20 mmHg in blood pressure, including ambulatory, office and home blood pressure | 6 months post-randomization | |
| Other | Incidences of substantially adjusting antihypertensive medications | 6 months post-randomization | A substantial adjustment of antihypertensive medications is defined as any changes in number of antihypertensive medications, or type of antihypertensive medications, or ≥ 50% dose change in any ongoing antihypertensive medications in the last two weeks. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02900729/registered